| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 67.571 | 8.230 | 14.865 | 38.907 | 26.436 | - | 856 | 892 | - | 814 |
| Total Income - EUR | 67.578 | 9.953 | 14.866 | 38.907 | 26.545 | - | 856 | 945 | - | 814 |
| Total Expenses - EUR | 25.740 | 21.181 | 14.852 | 17.469 | 14.284 | - | 15.035 | 15.797 | - | 3.381 |
| Gross Profit/Loss - EUR | 41.838 | -11.227 | 14 | 21.438 | 12.261 | - | -14.179 | -14.853 | - | -2.567 |
| Net Profit/Loss - EUR | 39.811 | -11.474 | -146 | 21.049 | 11.630 | - | -14.188 | -14.861 | - | -2.575 |
| Employees | 3 | 1 | 1 | 1 | 1 | - | 1 | 1 | - | 0 |
Check the financial reports for the company - Epiprax Consult Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 5.735 | 4.257 | 9.324 | 6.424 | - | 2.112 | 781 | - | 0 |
| Current Assets | 66.888 | 45.952 | 47.251 | 63.349 | 78.907 | - | 24.025 | 10.911 | - | 7.576 |
| Inventories | 13.951 | 3.594 | 762 | 2.452 | 3.358 | - | 3.389 | 3.432 | - | 3.740 |
| Receivables | 213 | 1.280 | 994 | 3.368 | 4.834 | - | 1.894 | 1.120 | - | 2.653 |
| Cash | 52.724 | 41.077 | 45.495 | 57.529 | 70.715 | - | 18.742 | 6.359 | - | 1.182 |
| Shareholders Funds | 63.044 | 50.926 | 49.919 | 70.052 | 80.325 | - | 18.510 | 3.706 | - | -6.551 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | - | 40 | 41 | - | 40 |
| Debts | 3.566 | 760 | 1.589 | 3.523 | 5.889 | - | 8.475 | 8.836 | - | 14.971 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | - | 0 | 0 | - | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8121 - 8121" | |||||||||
| CAEN Financial Year |
8121
|
|||||||||
Comments - Epiprax Consult Srl